RxDoctor Payments DataLook up a doctor →

Rizwan Danish, MD

Hematology & Oncology · Flint, MINPI 1720076284

Payments from drug & device makers

$49,230in general payments, 2019–2025

Across 1,996 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$7K
  • Novartis$6K
  • AstraZeneca$2K
  • Johnson & Johnson$2K
  • Genentech USA, Inc.$2K
  • Pfizer$1K
  • plus $26K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck112$7,357
Novartis163$6,196
AstraZeneca(2 entities)103$2,138
Johnson & Johnson(2 entities)101$2,031
Genentech USA, Inc.126$2,016
Pfizer108$1,385
Coherus Oncology, Inc.55$1,251
Eisai Inc.54$1,220
Amgen58$1,218
Astellas Pharma US Inc49$1,156
Sanofi48$1,089
GSK69$1,032
Regeneron Healthcare Solutions, Inc.30$1,024
Beigene USA, Inc.19$999
Partner Therapeutics, Inc.1$900
Incyte Corporation56$853
E.r. Squibb & Sons, L.L.C.46$818
Karyopharm Therapeutics Inc.22$776
Takeda Pharmaceuticals U.S.A., Inc.35$749
Bristol Myers Squibb44$737
AbbVie26$729
Lilly USA, LLC41$705
EMD Serono, Inc.22$617
Seagen Inc.29$599
Daiichi Sankyo Inc.29$592
Ipsen Biopharmaceuticals, Inc19$493
Exelixis Inc.20$460
Jazz Pharmaceuticals Inc.22$449
Rigel Pharmaceuticals, Inc.24$432
Gilead(2 entities)26$407
Puma Biotechnology, Inc.17$366
Pharmacyclics LLC, An Abbvie Company17$362
Bayer19$351
Array Biopharma Inc22$313
Legend Biotech USA Inc.12$308
Tempus AI, Inc10$279
Sobi, Inc13$277
AVEO Pharmaceuticals, Inc.16$265
Pharmaessentia USA Corporation12$259
Boehringer Ingelheim12$256
Acrotech Biopharma Inc.13$255
AMAG Pharmaceuticals, Inc.15$252
Taiho Oncology, Inc.12$234
Deciphera Pharmaceuticals Inc.12$220
Apellis Pharmaceuticals, Inc.12$220
Dendreon Pharmaceuticals LLC9$220
Octapharma USA, Inc.10$219
Pharmacosmos Therapeutics Inc.12$219
Blueprint Medicines Corporation11$217
Stemline Therapeutics Inc.9$179
Dova Pharmaceuticals6$176
ASD Specialty Healthcare, LLC3$166
Tersera Therapeutics LLC9$158
Servier Pharmaceuticals LLC9$155
Alnylam Pharmaceuticals Inc.9$149
Janssen Scientific Affairs, LLC7$144
Emmaus Medical, Inc.6$141
Sun Pharmaceutical Industries Inc.6$139
Genmab U.S., Inc.5$127
Mylan Institutional Inc.6$120

How this compares

$49,230 in reported general payments places this provider in the 75th percentile of 282 hematology & oncology providers in Michigan.

See all hematology & oncology providers in Michigan →

Medicare billing

Part B allowed, 2024
$5,070,242
Medicare patients
488
Services billed
221,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Flint

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →